Journal
ANNALS OF DIAGNOSTIC PATHOLOGY
Volume 12, Issue 6, Pages 445-457Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.anndiagpath.2008.10.001
Keywords
Interstitial lung disease; Respiratory bronchiolitis; Desquamative interstitial pneumonia; Langerhans cell histiocytosis; Smoking
Categories
Ask authors/readers for more resources
Pulmonary diseases associated with tobacco smoking are a complex group of disorders ranging from chronic obstructive pulmonary disease (COPD) to lung cancer. Interstitial lung diseases (ILDs) have only recently been linked to smoking. The ILDs related to smoking include respiratory bronchiolitis-associated interstitial lung disease, desquamative interstitial pneumonia, and pulmonary Langerhans cell histiocytosis. The relationship of smoking with each of these entities has been largely established oil the weight of epidemiologic evidence. Although they have been retained as distinct and separate conditions in various classifications of interstitial lung diseases, these 3 entities share a number of clinical, radiologic, and pathologic features Suggesting that they represent a spectrum of patterns of interstitial lung disease occurring in predisposed individuals who smoke. Evaluation of histologic features, particularly in surgical lung biopsy samples, is important in making the distinction between these disorders. However, even after tissue biopsy, it may sometimes be difficult to clearly separate these entities. The importance of making the distinction between them lies in the different clinical management strategies used. Further experimental evidence, including genetic information, may be important in improving our understanding of these diseases. (C) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
Article
Pathology
Focal cortical dysplasia is a frequent coexistent pathology in patients with Rasmussen's encephalitis
Georgi Galev, Richard A. Prayson
ANNALS OF DIAGNOSTIC PATHOLOGY (2024)
Article
Pathology
Granulomatous lobular mastitis co-existing with ductal carcinoma in situ: Report of three cases and review of the literature
Jianmin Zhu, Xiuming Miao, Xin Li, Yang Zhang, Yuan Lou, Hanhan Chen, Xiaofei Liu
Summary: Granulomatous lobular mastitis (GLM) is a rare and benign chronic breast disease that can be mistaken for early-onset breast cancer. This report describes three cases in which GLM coexisted with ductal carcinoma in situ (DCIS), highlighting how GLM may obscure the presence of concurrent DCIS based on clinical imaging and manifestations.
ANNALS OF DIAGNOSTIC PATHOLOGY (2024)
Article
Pathology
Comparative expression of trophoblast cell-surface antigen 2 (TROP2) in the different molecular subtypes of invasive breast carcinoma: An immunohistochemical study of 94 therapy-naive primary breast tumors
Richard B. Mertens, Elias P. Makhoul, Xiaomo Li, Farnaz Dadmanesh
Summary: This study compared the expression of TROP2 in different molecular subtypes of breast cancer and found that a majority of carcinomas in each subtype showed intermediate to high levels of TROP2 expression with a wide range of expression. These observations support further investigation of the efficacy of sacituzumab govitecan in all molecular subtypes of breast carcinoma. The wide range of TROP2 expression suggests its potential utility as a biomarker for predicting responsiveness to sacituzumab govitecan. Immunohistochemical staining for TROP2 is critical for identifying patients who are completely negative for TROP2 and may be least likely or unlikely to respond to this agent.
ANNALS OF DIAGNOSTIC PATHOLOGY (2024)
Article
Pathology
Prognostic implications of synaptophysin, CD56, thyroid transcription factor-1, and Ki-67 in pulmonary high-grade neuroendocrine carcinomas
Yulong He, Lei Zhao, Xiaorong Tang, Qinling Jiang, Xianling Zhao, Yilin Cao
Summary: This study explores the correlation between the expression of immunohistochemical markers and clinicopathological characteristics of pulmonary high-grade neuroendocrine carcinomas (HGNEC), and its impact on clinical outcomes. The results suggest that positive expression of certain markers is associated with reduced survival in HGNEC patients, and tumor stage is an important predictive factor for prognosis.
ANNALS OF DIAGNOSTIC PATHOLOGY (2024)